WASHINGTON (Reuters) - U.S. health regulators have said GlaxoSmithKline Plc's Advair is safe and effective to more widely treat patients with chronic obstructive pulmonary disease (COPD), the ...
April 20 (Reuters) - Teva Pharmaceutical Industries Ltd launched its asthma inhaler and the authorized generic of the drug on Thursday, nearly three months after it got U.S. approval to market a copy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback